Sales increase to EUR 276.5 million; EBITDA reported reaches EUR 31.4 million
Digitalisation and sales activities promote partners’ career development
Expansion of innovative product range provides for positive business outlook
LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today announced its final figures for the 2023 financial year.
Accordingly, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 276.5 million (2022*: EUR 269.4 million). This meant that the company achieved a slight increase in sales of around 3% year-over-year despite negative currency effects.
Furthermore, LR Health & Beauty SE achieved a normalized EBITDA of EUR 35.4 million in the 2023 financial year, compared to EUR 36.0 million in the previous year. EBITDA reported increased to EUR 31.4 million in 2023 compared to the previous year’s figure of EUR 31.1 million.
Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments:
“2023 was a very strong year for LR. We were able to drive forward our strategic initiatives, and many partners saw successful career developments. With BODY MISSION and Mind Master Gold, we managed to achieve two of the three best product launches in the history of our